15
Participants
Start Date
September 6, 2022
Primary Completion Date
November 22, 2022
Study Completion Date
Delgocitinib
Cream for topical application 20 mg/g
LEO Investigational Site, Hamburg
Lead Sponsor
LEO Pharma
INDUSTRY